Ebola Vaccine Market Scope, Size, Implementation, Analytical Overview, Forecast 2027

-
Ebola Vaccine Market
Ebola Vaccine Market

The Ebola virus disease (EVD) is a severe, often fatal illness caused by the Ebola virus. It was first identified in 1976 in the Democratic Republic of Congo (DRC) and has since caused sporadic outbreaks in several African countries, with the largest outbreak occurring between 2014 and 2016, primarily in Guinea, Liberia, and Sierra Leone.

The Ebola Vaccine Market is anticipated to expand as a result of factors such the rising number of Ebola cases in afflicted areas and the development of new vaccines.

The outbreak resulted in over 28,000 confirmed cases and 11,000 deaths. In response to the devastating outbreak, efforts to develop an Ebola vaccine were accelerated, leading to the approval of several vaccines.

The Ebola Vaccine Market has been growing steadily since the approval of the first vaccine in 2019. The market is primarily driven by the increasing incidence of Ebola outbreaks and the need to control their spread. The World Health Organization (WHO) has identified Ebola as one of the top threats to global health security, emphasizing the urgent need for effective vaccines to protect populations at risk.

Currently, there are two approved Ebola vaccines: rVSV-ZEBOV and Ad26.ZEBOV/MVA-BN-Filo. rVSV-ZEBOV was developed by Merck & Co. and was approved by the US Food and Drug Administration (FDA) in 2019. It is a single-dose vaccine that uses a live, attenuated vesicular stomatitis virus (VSV) vector to express the Ebola virus glycoprotein (GP).

Increasing government initiatives and attempts to create mRNA treatments, particularly in light of the COVID-19 pandemic, are likely to fuel the expansion of the global m-RNA Synthesis Service Market throughout the forecast period.

Ad26.ZEBOV/MVA-BN-Filo, developed by Janssen Pharmaceuticals, was approved by the European Medicines Agency (EMA) in July 2020. It is a two-dose vaccine that uses two different vectors, adenovirus 26 (Ad26) and modified vaccinia virus Ankara (MVA), to express Ebola virus proteins. The rise in fatality rates brought on by Ebola Vaccine Market is anticipated to have a significant impact on market expansion.

Both vaccines have shown high efficacy in clinical trials. rVSV-ZEBOV was found to be 97.5% effective in preventing Ebola virus disease in a phase III trial conducted during the 2014-2016 outbreak in Guinea. Ad26.ZEBOV/MVA-BN-Filo was found to be 100% effective in preventing Ebola virus disease in a phase III trial conducted in Sierra Leone during the same outbreak. Both vaccines have also shown a good safety profile, with only mild to moderate side effects reported.

Comments

Post a Comment

Popular posts from this blog

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f...
Read more

Endometrial Ablation Market Analysis, Industry Scope, Global Opportunity Analysis and Forecast Till 2027

-
Image
Endometrial Ablation Market Endometrial ablation is a procedure used to treat abnormally high uterine bleeding that cannot be managed by medicine by facilitating the destruction of the endometrium, a thin layer of the uterine wall. According to the American College of Obstetrics and Gynecology, Endometrial Ablation Market is not indicated for women who have endometrial diseases, endometrial hyperplasia, uterine cancer, a recent pregnancy, and specific uterine infections (ACOG). There are various endometrial ablation procedures available, including radiofrequency, heated fluid, heated balloon, electrosurgery, freezing, and microwave ablation techniques, depending on the technique and kind of patient being treated. The easy access to recently developed sophisticated ablation technology, convenience of use, shorter treatment times, and outpatient facilities, North America dominates the Endometrial Ablation Market . Endometrial ablation devices would see a sharp rise in global adoption d...
Read more

Artificial Intelligence And Machine Learning Are Fueling Growth Of Assessment Services Market

-
Image
Assessment Services Market The global Assessment Services Market is estimated to be valued at US$ 14.83 Bn in 2022 and is expected to exhibit a CAGR of 9.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Assessment services help companies evaluate candidates for recruitment based on attributes like critical thinking, decision making, problem solving etc. Employers use these tools to hire best talent aligned with organizational goals and culture. Services include cognitive ability tests, personality tests, situational judgement tests, remote proctoring and AI powered video interviews. Market key trends: The growing adoption of data-driven talent selection strategies coupled with developments in AI and machine learning is driving demand for assessment services. Use of algorithms and neural networks powered by big data helps analyze candidate attributes and person-organization fit more objectively. Virtual asses...
Read more